TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression

Oncogene

Volumn 30, Issue 27, 2011, Pages 3049-3061

  Seux, M ^a,b   Peuget, S ^a,b   Montero, M P ^c   Siret, C ^c   Rigot, V ^c   Clerc, P ^d   Gigoux, V ^d   Pellegrino, E ^c   Pouyet, L ^a,b   N'Guessan, P ^a,b   Garcia, S ^a,b   Dufresne, M ^d   Iovanna, J L ^a,b   Carrier, A ^a,b   Andre F ^c   Dusetti, N J ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c University of the Mediterranean Aix Marseille II   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

migration; pancreatic cancer; PanIN; SPARC; TP53INP1

Indexed keywords

BETA TUBULIN; MICRORNA; NUCLEAR PROTEIN; OSTEONECTIN; PROTEIN P53; PROTEIN TP53INP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; CARCINOGENESIS; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EXTRACELLULAR MATRIX; FIBROBLAST; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALIA;

EID: 79960047108     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.25     Document Type: Article

References (54)

1. Arnold S, Mira E, Muneer S, Korpanty G, Beck AW, Holloway SE et al. (2008). Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC. Exp Biol Med (Maywood) 233: 860-873.
2. Basu A, Kligman LH, Samulewicz SJ, Howe CC. (2001). Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40). BMC Cell Biol 2: 15.
3. Baumgart M, Heinmoller E, Horstmann O, Becker H, Ghadimi BM. (2005). The genetic basis of sporadic pancreatic cancer. Cell Oncol 27: 3-13. (Pubitemid 40387188)
4. Bellahcene A, Castronovo V. (1995). Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 146: 95-100.
5. Bradshaw AD, Puolakkainen P, Dasgupta J, Davidson JM, Wight TN, Helene Sage E. (2003). SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 120: 949-955. (Pubitemid 36702902)
6. Bradshaw AD, Reed MJ, Sage EH. (2002). SPARC-null mice exhibit accelerated cutaneous wound closure. J Histochem Cyto-chem 50: 1-10. (Pubitemid 34074617)
7. Bradshaw AD, Sage EH. (2001). SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107: 1049-1054. (Pubitemid 32422898)
8. Brekken RA, Puolakkainen P, Graves DC, Workman G, Lubkin SR, Sage EH. (2003). Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. J Clin Invest 111: 487-495. (Pubitemid 36228006)
9. Brune K, Hong SM, Li A, Yachida S, Abe T, Griffith M et al. (2008). Genetic and epigenetic alterations of familial pancreatic cancers. Cancer Epidemiol Biomarkers Prev 17: 3536-3542.
10. Chen G, Tian X, Liu Z, Zhou S, Schmidt B, Henne-Bruns D et al. (2010). Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression. Br J Cancer 102: 188-195.
11. Ford R, Wang G, Jannati P, Adler D, Racanelli P, Higgins PJ et al. (1993). Modulation of SPARC expression during butyrate-induced terminal differentiation of cultured human keratinocytes: regulation via a TGF-beta-dependent pathway. Exp Cell Res 206: 261-275. (Pubitemid 23212944)
12. Framson PE, Sage EH. (2004). SPARC and tumor growth: where the seed meets the soil J Cell Biochem 92: 679-690. (Pubitemid 44264259)
13. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J et al. (2007). Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 104: 16170-16175. (Pubitemid 350099380)
14. Gommeaux J, Cano C, Garcia S, Gironella M, Pietri S, Culcasi M et al. (2007). Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol 27: 2215-2228. (Pubitemid 46418477)
15. Guweidhi A, Kleeff J, Adwan H, Giese NA, Wente MN, Giese T et al. (2005). Osteonectin influences growth and invasion of pancreatic cancer cells. Ann Surg 242: 224-234. (Pubitemid 41033439)
16. Hershko T, Chaussepied M, Oren M, Ginsberg D. (2005). Novel link between E2F and p53: proapoptotic cofactors of p53 are transcrip-tionally upregulated by E2F. Cell Death Differ 12: 377-383. (Pubitemid 40520689)
17. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA et al. (2003). Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4: 437-450. (Pubitemid 38050041)
18. Hunzelmann N, Hafner M, Anders S, Krieg T, Nischt R. (1998). BM-40 (osteonectin, SPARC) is expressed both in the epidermal and in the dermal compartment of adult human skin. J Invest Dermatol 110: 122-126. (Pubitemid 28105844)
19. Infante JR, Matsubayashi H, Sato N, Tonascia J, Klein AP, Riall TA et al. (2007). Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. J Clin Oncol 25: 319-325. (Pubitemid 350003021)
20. Ito Y, Motoo Y, Yoshida H, Iovanna JL, Takamura Y, Miya A et al. (2006). Decreased expression of tumor protein p53-induced nuclear protein 1 (TP53INP1) in breast carcinoma. Anticancer Res 26: 4391-4395. (Pubitemid 46031512)
21. Jiang PH, Motoo Y, Garcia S, Iovanna JL, Pebusque MJ, Sawabu N. (2006). Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World J Gastroenterol 12: 691-696. (Pubitemid 43380749)
22. Loging WT, Lal A, Siu IM, Loney TL, Wikstrand CJ, Marra MA et al. (2000). Identifying potential tumor markers and antigens by database mining and rapid expression screening. Genome Res 10: 1393-1402.
23. Lomberk G, Mathison AJ, Grzenda A, Urrutia R. (2008). The sunset of somatic genetics and the dawn of epigenetics: a new frontier in pancreatic cancer research. Curr Opin Gastroenterol 24: 597-602.
24. Martin P. (1997). Wound healing-aiming for perfect skin regeneration. Science 276: 75-81. (Pubitemid 27161246)
25. Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M. (1999). Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas. Hum Pathol 30: 339-344. (Pubitemid 29125155)
26. Murphy-Ullrich JE, Lane TF, Pallero MA, Sage EH. (1995). SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand. J Cell Biochem 57: 341-350.
27. Ogawa K, Asamoto M, Suzuki S, Tsujimura K, Shirai T. (2005). Downregulation of apoptosis revealed by laser microdissection and cDNA microarray analysis of related genes in rat liver preneoplastic lesions. Med Mol Morphol 38: 23-29. (Pubitemid 351543886)
28. Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P et al. (1995). Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/ SPARC genes. Int J Cancer 64: 70-75.
29. Porte H, Triboulet JP, Kotelevets L, Carrat F, Prevot S, Nordlinger B et al. (1998). Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. Clin Cancer Res 4: 1375-1382. (Pubitemid 28265219)
30. Porter PL, Sage EH, Lane TF, Funk SE, Gown AM. (1995). Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem 43: 791-800.
31. Puolakkainen PA, Brekken RA, Muneer S, Sage EH. (2004). Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. Mol Cancer Res 2: 215-224. (Pubitemid 39031082)
32. Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bornstein P, Sage EH. (1993). Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem 41: 1467-1477. (Pubitemid 23275248)
33. Reed MJ, Vernon RB, Abrass IB, Sage EH. (1994). TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J Cell Physiol 158: 169-179.
34. Rempel SA, Golembieski WA, Fisher JL, Maile M, Nakeff A. (2001). SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. J Neurooncol 53: 149-160. (Pubitemid 33034688)
35. Rempel SA, Golembieski WA, Ge S, Lemke N, Elisevich K, Mikkelsen T et al. (1998). SPARC: a signal of astrocytic neoplastic transformation and reactive response in human primary and xenograft gliomas. J Neuropathol Exp Neurol 57: 1112-1121. (Pubitemid 28562739)
36. Robert G, Gaggioli C, Bailet O, Chavey C, Abbe P, Aberdam E et al. (2006). SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Cancer Res 66: 7516-7523. (Pubitemid 44289206)
37. Roger L, Gadea G, Roux P. (2006). Control of cell migration: a tumour suppressor function for p53? Biol Cell 98: 141-152. (Pubitemid 43336806)
38. Ryu B, Jones J, Hollingsworth MA, Hruban RH, Kern SE. (2001). Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 61: 1833-1838. (Pubitemid 32691994)
39. Sage EH, Bassuk JA, Yost JC, Folkman MJ, Lane TF. (1995). Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence. J Cell Biochem 57: 127-140.
40. Sage EH, Reed M, Funk SE, Truong T, Steadele M, Puolakkainen P et al. (2003). Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J Biol Chem 278: 37849-37857. (Pubitemid 37175313)
41. Sage H, Vernon RB, Decker J, Funk S, Iruela-Arispe ML. (1989). Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. J Histochem Cytochem 37: 819-829. (Pubitemid 19156464)
42. Sato N, Fukushima N, Maehara N, Matsubayashi H, Koopmann J, Su GH et al. (2003). SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene 22: 5021-5030. (Pubitemid 37026400)
43. Schiemann BJ, Neil JR, Schiemann WP. (2003). SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system. Mol Biol Cell 14: 3977-3988. (Pubitemid 37186302)
44. Seno T, Harada H, Kohno S, Teraoka M, Inoue A, Ohnishi T. (2009). Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas. Int J Oncol 34: 707-715.
45. Singer AJ, Clark RA. (1999). Cutaneous wound healing. N Engl J Med 341: 738-746. (Pubitemid 29407375)
46. Suzuki S, Asamoto M, Tsujimura K, Shirai T. (2004). Specific differences in gene expression profile revealed by cDNA microarray analysis of glutathione S-transferase placental form (GST-P) immunohistochemically positive rat liver foci and surrounding tissue. Carcinogenesis 25: 439-443. (Pubitemid 38344412)
47. Tomasini R, Samir AA, Carrier A, Isnardon D, Cecchinelli B, Soddu S et al. (2003). TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J Biol Chem 278: 37722-37729. (Pubitemid 37175297)
48. Tomasini R, Samir AA, Pebusque MJ, Calvo EL, Totaro S, Dagorn JC et al. (2002). P53-dependent expression of the stress-induced protein (SIP). Eur J Cell Biol 81: 294-301. (Pubitemid 34568210)
49. Tomasini R, Samir AA, Vaccaro MI, Pebusque MJ, Dagorn JC, Iovanna JL et al. (2001). Molecular and functional characterization of the stress-induced protein (SIP) gene and its two transcripts generated by alternative splicing. SIP induced by stress and promotes cell death. J Biol Chem 276: 44185-44192.
50. Vasseur S, Hoffmeister A, Garcia-Montero A, Barthet M, Saint-Michel L, Berthezene P et al. (2003). Mice with targeted disruption of p8 gene show increased sensitivity to lipopolysaccharide and DNA microarray analysis of livers reveals an aberrant gene expression response. BMC Gastroenterol 3: 25.
51. Verrecchia F, Mauviel A. (2007). Transforming growth factor-beta and fibrosis. World J Gastroenterol 13: 3056-3062.
52. Wrana JL, Overall CM, Sodek J. (1991). Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen. Eur J Biochem 197: 519-528.
53. Yamanaka M, Kanda K, Li NC, Fukumori T, Oka N, Kanayama HO et al. (2001). Analysis of the gene expression of SPARC and its prognostic value for bladder cancer. J Urol 166: 2495-2499. (Pubitemid 33065342)
54. Yoshida K, Liu H, Miki Y. (2006). Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage. J Biol Chem 281: 5734-5740. (Pubitemid 43847672)